INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 5388 participants.
Also called NCT02787044
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 5,388 participants
- Sponsor
- Registry
-
NCT02787044
-
- Main results
- Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial
- Other papers using this trial's data
- Educational Attainment Level and Risk of Mortality and Cardiopulmonary Outcomes in High-Risk Patients With Cardiovascular Disease: The INVESTED Trial
- Influenza Vaccine Immune Response in Patients With High-Risk Cardiovascular Disease: A Secondary Analysis of the INVESTED Randomized Clinical Trial
- Temporal Association Among Influenza-Like Illness, Cardiovascular Events, and Vaccine Dose in Patients With High-Risk Cardiovascular Disease: Secondary Analysis of a Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada, Puerto Rico
- Registry status
- Completed
Technical summary
Registry record NCT02787044. Randomized; quadruple masking; primary purpose prevention. Start 2016-08-01 (actual); primary completion 2020-05-31 (actual). Results posted on 2021-09-14.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
- Acronym
- INVESTED
- Condition
- Heart Failure
- Condition
- Myocardial Infarction
- Intervention (Biological)
- High Dose Trivalent Influenza Vaccine
- Intervention (Biological)
- Standard Dose Quadrivalent Influenza Vaccine
- Lead sponsor
- Brigham and Women's Hospital
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator
- University of Wisconsin, Madison
- Collaborator
- University of Toronto
- Collaborator
- Boston VA Research Institute, Inc.
- Collaborator
- Patient-Centered Outcomes Research Institute
- Collaborator
- University of Minnesota
Record details
- Record id
cardio:ct-nct02787044- Content hash
658c467b38955800a4142f1b08c508b0b855be2f5482dad81dc5a931b2254478